Patients, Privacy and Competitive Advantage
How effective is your organization at leveraging data across the entirety of the drug development cycle? This session considers how safe data strategies can fuel competitive advantage and improvements in patient treatment, starting with disease detection.
In this webinar, we dissect today’s dynamic business environment and expose foundational privacy capabilities to fuel innovation while protecting brand trust.
Presenters: Sarah Lyons, General Manager, Privacy Analytics and Ben Hughes SVP, Artificial Intelligence (AI) & Real World Data (RWD), IQVIA
Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.
Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.
Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.
Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.
Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.
This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.